Medicamen Organics (NSE:MEDIORG) Net Margin %: -126.78% (As of Mar. 2026)


NSE:MEDIORG Medicamen Organics Ltd NSE:MEDIORG
21 GF Score
Price ₹24.20
! 11 Warning Signs
View Full Analysis

What is Medicamen Organics Net Margin %?

Medicamen Organics NSE:MEDIORG -2.81% 21 Net Margin % is -126.78% as of Mar. 2026. GuruFocus rates NSE:MEDIORG with a GF Score™ of 21/100. The stock has 11 warning signs investors should review. Among 954 Drug Manufacturers companies, Medicamen Organics ranks worse than 92.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Medicamen Organics's Net Income for the six months ended in Mar. 2026 was ₹-60.57 Mil. Medicamen Organics's Revenue for the six months ended in Mar. 2026 was ₹47.78 Mil. Therefore, Medicamen Organics's net margin for the quarter that ended in Mar. 2026 was -126.78%.

The historical rank and industry rank for Medicamen Organics's Net Margin % or its related term are showing as below:

NSE:MEDIORG' s Net Margin % Range Over the Past 10 Years
Min: -126.78   Med: 2.79   Max: 10.6
Current: -126.78

NSE:MEDIORG's Net Margin % is ranked worse than
92.14% of 954 companies
in the Drug Manufacturers industry
Industry Median: 5.695 vs NSE:MEDIORG: -126.78

Medicamen Organics  (NSE:MEDIORG) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Medicamen Organics Net Margin % Related Terms

Medicamen Organics Net Margin % Historical Data

* Premium members only.

The historical data trend for Medicamen Organics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicamen Organics Net Margin % Chart

Medicamen Organics Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Margin %
Get a 7-Day Free Trial 0.48 4.38 10.38 10.60 -17.76

Medicamen Organics Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Mar25 Mar26
Net Margin % Get a 7-Day Free Trial 0.00 11.41 9.56 11.76 -126.78

NSE:MEDIORG vs ZTS, UTHR: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medicamen Organics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicamen Organics Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicamen Organics's Net Margin % distribution charts can be found below:

* The bar in red indicates where Medicamen Organics's Net Margin % falls into.


NSE:MEDIORG
21GF Score
Medicamen Organics Ltd NSE:MEDIORG
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicamen Organics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Medicamen Organics's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-40.194/226.303
=-17.76 %

Medicamen Organics's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-60.574/47.78
=-126.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -126.78% mean?
Medicamen Organics (NSE:MEDIORG) has a Net Margin % of -126.78% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Medicamen Organics and its competitors. According to the industry distribution chart, Medicamen Organics ranks #879 out of 954 companies in the Drug Manufacturers industry, placing it in the top 92.1%.
Is Medicamen Organics' Net Margin % too high?
Medicamen Organics' current Net Margin % is -126.78%. Based on the distribution chart, Medicamen Organics ranks #879 out of 954 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Medicamen Organics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Medicamen Organics' Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Medicamen Organics ranks #879 out of 954 companies for Net Margin %. This places Medicamen Organics in the lower half of its industry. The industry median Net Margin % is 5.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.70, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Medicamen Organics and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicamen Organics's current Net Margin % is -126.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicamen Organics stock overvalued right now?
Medicamen Organics (NSE:MEDIORG) has a current Net Margin % of -126.78%. The current Net Margin % is -126.78%. Medicamen Organics' overall GF Score™ is 21/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Medicamen Organics (NSE:MEDIORG), the current Net Margin % is -126.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicamen Organics Business Description

Address Ashok Vihar Phase II, 10, Community Center No. 2, New Delhi, IND, 110052
Medicamen Organics Ltd develops, manufactures, and distributes a wide range of pharmaceutical dosage forms, including Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders. The company operates two WHO Good Manufacturing Practice certified facilities in India, producing products for both domestic and international clients. It provides contract manufacturing and loan license services to various pharmaceutical companies and exports to several countries across Africa, CIS, and South Asia. The principal source of revenue is through the manufacturing, export, and contract services focused on generic and branded pharmaceutical formulations.
21GF Score

Get the complete analysis for NSE:MEDIORG

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹24.20
Price